Market Value1,052,825,948
Total Holdings75
File Date2023-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
FNA / Paragon 28, Inc.
TNDM / Tandem Diabetes Care, Inc.
RPHM / Reneo Pharmaceuticals, Inc.
PLRX / Pliant Therapeutics, Inc.
TCMD / Tactile Systems Technology, Inc.
INSM / Insmed Incorporated
SONXD / Sonendo, Inc.
AVTR / Avantor, Inc.
OMCL / Omnicell, Inc.
NEO / NeoGenomics, Inc.
TELA / TELA Bio, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
HALO / Halozyme Therapeutics, Inc.
PFE / Pfizer Inc.
MIRO / Miromatrix Medical Inc
XENE / Xenon Pharmaceuticals Inc.
GILD / Gilead Sciences, Inc.
CUTR / Cutera, Inc.
TMDX / TransMedics Group, Inc.
JNJ / Johnson & Johnson
SCTL / Societal CDMO, Inc.
GSK / GSK plc - Depositary Receipt (Common Stock)
QDEL / QuidelOrtho Corporation
OGN / Organon & Co.
RVTY / Revvity, Inc.
GH / Guardant Health, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
CNC / Centene Corporation
GMAB / Genmab A/S - Depositary Receipt (Common Stock)
OPRX / OptimizeRx Corporation
AXNX / Axonics, Inc.
MODN / Model N, Inc.
STVN / Stevanato Group S.p.A.
PRTA / Prothena Corporation plc
SNN / Smith & Nephew plc - Depositary Receipt (Common Stock)
ZNTL / Zentalis Pharmaceuticals, Inc.
CSTL / Castle Biosciences, Inc.
KRYS / Krystal Biotech, Inc.
ABCZF / Abcam Limited
OM / Outset Medical, Inc.
SYNH / Syneos Health Inc - Class A
RETA / Reata Pharmaceuticals Inc - Class A
AKU / Akumin Inc
KROS / Keros Therapeutics, Inc.
KIDS / OrthoPediatrics Corp.
PDCO / Patterson Companies, Inc.
ATEC / Alphatec Holdings, Inc.
ENOV / Enovis Corporation
BAYZF / Bayer Aktiengesellschaft
TECH / Bio-Techne Corporation
MDT / Medtronic plc
KRTX / Karuna Therapeutics, Inc.
BMRN / BioMarin Pharmaceutical Inc.
ELV / Elevance Health, Inc.
LH / Labcorp Holdings Inc.
HUM / Humana Inc.
IART / Integra LifeSciences Holdings Corporation
QGEN / Qiagen N.V.
HCA / HCA Healthcare, Inc.
FMS / Fresenius Medical Care AG - Depositary Receipt (Common Stock)
EXEL / Exelixis, Inc.
BIIB / Biogen Inc.
IRTC / iRhythm Holdings, Inc.
KRMD / KORU Medical Systems, Inc.
PHLT / Performant Healthcare, Inc.
HCAT / Health Catalyst, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
ANAB / AnaptysBio, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
ATRC / AtriCure, Inc.
XRAY / DENTSPLY SIRONA Inc.
SLP / Simulations Plus, Inc.
SIBN / SI-BONE, Inc.
AXGN / Axogen, Inc.
MXCT / MaxCyte, Inc.
NVS / Novartis AG - Depositary Receipt (Common Stock)
ABBV / AbbVie Inc.
SNY / Sanofi - Depositary Receipt (Common Stock)
UTHR / United Therapeutics Corporation
VTRS / Viatris Inc.
TAK / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)
OFIX / Orthofix Medical Inc.